COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1420: Articles 14191-14200  | Next

Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E
Zhu, Y., Scholle, F., Kisthardt, S. C., Xie, D.
10.1101/2021.07.01.450756 — Posted: 2021-07-02
Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2' by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2
Essalmani, R., Jain, J., Susan-Resiga, D., Andreo, U., Evagelidis, A., Derbali, M., Huynh, D., Dallaire, F., Laporte, M., Delpal, A., Sutto-Ortiz, P., Coutard, B., Mapa, C., Wilcoxen, K., Decroly, E., Pham, T. N., Cohen, E. A., Seidah, N. G.
10.1101/2021.07.02.450896 — Posted: 2021-07-02
Betacoronavirus-specific alternate splicing
Karlebach, G., Aronow, B. J., Baylin, S. J., Butler, D., Foox, J., Levy, S., Meydan, C., Mozsary, C., Saravia-Butler, A. M., Taylor, D. M., Wurtele, E., Mason, C., Beheshti, A., Robinson, P. N.
10.1101/2021.07.02.450920 — Posted: 2021-07-02
Proxalutamide (GT0918) Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration - an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
Zimerman, R. A., Fonseca, D. N., Correia, M. N., Barros, R. N., Onety, D. C., Israel, K. C. P., Guerreiro, E. O., Medeiros, J. E. M., Nicolau, R. N., Nicolau, L. F. M., da Silva, P. S., Cunha, R. X., Barroco, M. F. R., Paulain, R. W., Thompson, C. E., Goren, A., Cadegiani, F. A.
10.1101/2021.06.28.21259661 — Posted: 2021-07-02 Discussion: Onsite | Offsite
Proxalutamide (GT0918) Improves Lung Injury in Hospitalized COVID-19 Patients - an Analysis of the Radiological Findings of the Proxa-Rescue AndroCoV Trial
Cadegiani, F. A., Fonseca, D. N., Correia, M. N., Barros, R. N., Onety, D. C., Israel, K. C. P., Guerreiro, E. O., Medeiros, J. E. M., Nicolau, R. N., Nicolau, L. F. M., Cunha, R. X., Barroco, M. F. R., Silva, P. S., Paulain, R. W., Thompson, C. E., Zimerman, R. A., Goren, A., Wambier, C. G.
10.1101/2021.07.01.21259656 — Posted: 2021-07-02 Discussion: Onsite | Offsite
Estimating the death toll of the Covid-19 pandemic in India
Guilmoto, C. Z.
10.1101/2021.06.29.21257965 — Posted: 2021-07-02
Evolution of Anti-SARS-CoV-2 IgG Antibody and IgG Avidity Post Pfizer and Moderna mRNA Vaccinations
Bliden, K. P., Liu, T., Sreedhar, D., Kost, J., Hsiung, J., Zhao, S., Shan, D., Usman, A., Walia, N., Cho, A., Jerjian, C., Tantry, U. S., Gurbel, P. A., Tang, M., Dai, H.
10.1101/2021.06.28.21259338 — Posted: 2021-07-02
Transmissibility of COVID-19 among Vaccinated Individuals: A Rapid Literature Review
Egunsola, O., Mastikhina, L., Dowsett, L., Farkas, B., Hofmeister, M., Saxinger, L., Clement, F.
10.1101/2021.06.29.21255526 — Posted: 2021-07-02
The acceptance of covid-19 vaccines in Sub-Saharan Africa: Evidence from 6 national phone surveys
Kanyanda, S., Markhof, Y., Wollburg, P., Zezza, A.
10.1101/2021.06.28.21259320 — Posted: 2021-07-02
Enhancing epidemiological investigation of nosocomial SARS-CoV-2 infection with whole genome sequencing: A retrospective cohort study across four hospitals in the UK.
Lumley, S. F., Constantinides, B., Sanderson, N., Rodger, G., Street, T. L., Swann, J., Chau, K. K., O'Donnell, D., Warren, F., Hoosdally, S., OUH Microbiology laboratory, , OUH Infection Prevention and Control team, , O'Donnell, A.-M., Walker, T. M., Stoesser, N. E., Butcher, L., Peto, T. E., Crook, D. W., Jeffery, K., Matthews, P. C., Eyre, D. W.
10.1101/2021.06.28.21259028 — Posted: 2021-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).